当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Norman S Miller and Zeinab A Saad
The medical justification as to the risks and benefits associated with the use of marijuana for medical purposes is not supported by current medical research and state and federal laws in the United States. State endorsed “medical marijuana” currently take the form of a dried plant, cannabis sativa. State laws in favor of legalizing marijuana for medical use fail to incorporate the general legal standards for medical practice and are created absent any uniformed guidelines. These attempts to circumvent federal law lack the support of the medical and legal community as they overlook the standards for safety and effectiveness established by the Food and Drug Administration for medical use. With a growing public demand for marijuana, states have merely attempted to bypass the federal government’s current regulations on marijuana by legalizing such laws.